metabolic syndrome. Encounter for screening for nutritional, metabolic and other endocrine disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed by a physician suffering from metabolic syndrome Premenopausal women using a reliable contraceptive method and postmenopausal women on stable hormone replacement therapy. The individual should either be a non-smoker or smoke fewer than 10 cigarettes per day. No use of oral contraceptives, estrogen, progesterone, corticosteroids, or insulin. No adherence to specific diets such as vegetarian, ketogenic, etc. Not suffering from metabolic disorders such as diabetes or uncontrolled thyroid disorders. Aged between 18 to 65 No regular consumption of dietary supplements or "functional foods" containing spirulina or probiotics No weight loss of more than 5% in the past 3 months No specific exercise regimen
Exclusion criteria
Exclusion criteria: Not living in Shiraz.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: with an accuracy of 100 grams using scale.;Waist circumference. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: With accuracy of 0.1 cm, using sewing meter.;Body mass index (BMI). Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Automatically is calculated (weight / Height^2).;Serum levels of triglycerides. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of total cholesterol. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of LDL. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of HDL. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Serum levels of gamma-glutamyl transferase (GGT). Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Blood tests are conducted at Dr. Kaviani's laboratory.;Fatty liver index. Timepoint: Before intervention and 2 months after the start of the intervention. Method of measurement: Using formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences